CinRock Pharma Overview
- Year Founded
-
2026
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
CinRock Pharma General Information
Description
Developer of selective rock2 inhibitors designed to treat cardiovascular diseases. The company utilizes selective rho-associated protein kinase 2 inhibition, focuses on anti-fibrotic and anti-inflammatory effects, employs compounds with cardiac tissue distribution, targets underlying pathophysiology of fibrosis, and leverages a hub-and-spoke development model, enabling the biopharmaceutical sector to access oral treatments for pulmonary arterial hypertension and heart failure.
Contact Information
Website
www.cinrock.comCorporate Office
- United States
Corporate Office
- United States
CinRock Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CinRock Pharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
CinRock Pharma FAQs
-
When was CinRock Pharma founded?
CinRock Pharma was founded in 2026.
-
Where is CinRock Pharma headquartered?
CinRock Pharma is headquartered in .
-
What industry is CinRock Pharma in?
CinRock Pharma’s primary industry is Drug Discovery.
-
Is CinRock Pharma a private or public company?
CinRock Pharma is a Private company.
-
What is CinRock Pharma’s current revenue?
The current revenue for CinRock Pharma is .
-
Who are CinRock Pharma’s investors?
CinRx Pharma and Graviton BioScience have invested in CinRock Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process